GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 785 filers reported holding GLAXOSMITHKLINE PLC in Q1 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,000 | -33.3% | 57 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -50.0% | 57 | -63.7% | 0.00% | -100.0% |
| Q3 2021 | $6,000 | 0.0% | 157 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $6,000 | 0.0% | 157 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $6,000 | +200.0% | 157 | +175.4% | 0.00% | – |
| Q4 2020 | $2,000 | -71.4% | 57 | -70.2% | 0.00% | -100.0% |
| Q3 2020 | $7,000 | -12.5% | 191 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $8,000 | +14.3% | 191 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $7,000 | +16.7% | 191 | +42.5% | 0.00% | +100.0% |
| Q4 2019 | $6,000 | 0.0% | 134 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $6,000 | +20.0% | 134 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $5,000 | -16.7% | 134 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $6,000 | +20.0% | 134 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $5,000 | -28.6% | 134 | -20.2% | 0.00% | 0.0% |
| Q3 2018 | $7,000 | +40.0% | 168 | +26.3% | 0.00% | 0.0% |
| Q2 2018 | $5,000 | 0.0% | 133 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $5,000 | – | 133 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |